AVR anteris technologies global corp.

the current study advertised on clinical trial (n = 40) of first...

  1. 252 Posts.
    lightbulb Created with Sketch. 45
    the current study advertised on clinical trial (n = 40) of first time or VIV replacement will add to that information.........data hopefully available in the next 18 months.......

    I agree about the dilution impact - the upside of the anticipated potential pie in the sky dream SP is still there and could (should) exceed the dilution effect....it just may take longer than many of us hope for......
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$6.03
Change
0.010(0.17%)
Mkt cap ! $93.45M
Open High Low Value Volume
$6.00 $6.16 $5.80 $52.24K 8.792K

Buyers (Bids)

No. Vol. Price($)
1 857 $5.83
 

Sellers (Offers)

Price($) Vol. No.
$6.45 1000 1
View Market Depth
Last trade - 15.36pm 20/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.